Moreover, expression of DLX2 and DLX5 have been reported to be mutually exclusive in breast cancer, with DLX2 expression being significantly correlated with a favorable prognosis, whereas DLX5 was associated with metastasis [75]. This evidence concerns the gene DLX5 and breast carcinoma.